REFERENCES
1. [Anonym]. Headache Classification Committee of the International
Headache Society (IHS) The International Classification of Headache
Disorders, 3rd edition. Cephalalgia 2018; 38: 1-211.
doi:10.1177/0333102417738202
2. Lipton RB, Silberstein SD. Episodic and chronic migraine headache:
breaking down barriers to optimal treatment and prevention. Headache
2015; 55 Suppl 2: 103-122; quiz 123-106. doi:10.1111/head.12505_2
3. Baykan B, Ertas M, Karli N et al. Migraine incidence in 5 years: a
population-based prospective longitudinal study in Turkey. J Headache
Pain 2015; 16: 103. doi:10.1186/s10194-015-0589-2
4. Caputi CA, Firetto V. Therapeutic blockade of greater occipital and
supraorbital nerves in migraine patients. Headache 1997; 37: 174-179.
doi:10.1046/j.1526-4610.1997.3703174.x
5. Inan LE, Inan N, Unal-Artik HA et al. Greater occipital nerve block
in migraine prophylaxis: Narrative review. Cephalalgia 2019; 39:
908-920. doi:10.1177/0333102418821669
6. Kerr FW, Olafson RA. Trigeminal and cervical volleys. Convergence on
single units in the spinal gray at C-1 and C-2. Arch Neurol 1961; 5:
171-178. doi:10.1001/archneur.1961.00450140053005
7. Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve
induces increased central excitability of dural afferent input. Brain
2002; 125: 1496-1509. doi:10.1093/brain/awf166
8. Ashkenazi A, Young WB. The effects of greater occipital nerve block
and trigger point injection on brush allodynia and pain in migraine.
Headache 2005; 45: 350-354. doi:10.1111/j.1526-4610.2005.05073.x
9. Afridi SK, Shields KG, Bhola R et al. Greater occipital nerve
injection in primary headache syndromes–prolonged effects from a
single injection. Pain 2006; 122: 126-129.
doi:10.1016/j.pain.2006.01.016
10. Blumenfeld A, Ashkenazi A, Napchan U et al. Expert consensus
recommendations for the performance of peripheral nerve blocks for
headaches–a narrative review. Headache 2013; 53: 437-446.
doi:10.1111/head.12053
11. Saracco MG, Valfre W, Cavallini M et al. Greater occipital nerve
block in chronic migraine. Neurol Sci 2010; 31 Suppl 1: S179-180.
doi:10.1007/s10072-010-0320-7
12. Ashkenazi A, Matro R, Shaw JW et al. Greater occipital nerve block
using local anaesthetics alone or with triamcinolone for transformed
migraine: a randomised comparative study. J Neurol Neurosurg Psychiatry
2008; 79: 415-417. doi:10.1136/jnnp.2007.124420
13. Ambrosini A, Vandenheede M, Rossi P et al. Suboccipital injection
with a mixture of rapid- and long-acting steroids in cluster headache: a
double-blind placebo-controlled study. Pain 2005; 118: 92-96.
doi:10.1016/j.pain.2005.07.015
14. Tetzlaff JE. The pharmacology of local anesthetics. Anesthesiol Clin
North Am 2000; 18: 217-233, v. doi:10.1016/s0889-8537(05)70161-9
15. Gul HL, Ozon AO, Karadas O et al. The efficacy of greater occipital
nerve blockade in chronic migraine: A placebo-controlled study. Acta
Neurol Scand 2017; 136: 138-144. doi:10.1111/ane.12716
16. Dilli E, Halker R, Vargas B et al. Occipital nerve block for the
short-term preventive treatment of migraine: A randomized,
double-blinded, placebo-controlled study. Cephalalgia 2015; 35: 959-968.
doi:10.1177/0333102414561872
17. Kashipazha D, Nakhostin-Mortazavi A, Mohammadianinejad SE et al.
Preventive effect of greater occipital nerve block on severity and
frequency of migraine headache. Glob J Health Sci 2014; 6: 209-213.
doi:10.5539/gjhs.v6n6p209
18. Unal-Artik HA, Inan LE, Atac-Ucar C et al. Do bilateral and
unilateral greater occipital nerve block effectiveness differ in chronic
migraine patients? Neurol Sci 2017; 38: 949-954.
doi:10.1007/s10072-017-2861-5
19. Takmaz SA, Inan N, Ucler S et al. Greater occipital nevre block in
migraine headache: Preliminary results of 10 patients. Ağrı 2008; 20:
47-50
20. Okmen K, Dagistan Y, Dagistan E et al. Efficacy of the greater
occipital nerve block in recurrent migraine type headaches. Neurol
Neurochir Pol 2016; 50: 151-154. doi:10.1016/j.pjnns.2016.01.015
21. Ruiz Piñero M, Mulero Carrillo P, Pedraza Hueso MI et al.
Pericranial nerve blockade as a preventive treatment for migraine:
Experience in 60 patients. Neurologia (Barcelona, Spain) 2016; 31:
445-451. doi:10.1016/j.nrl.2014.10.001